CAROLINE SCHULOF: Open Payments
NPI 1639695026 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 12 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $201 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $248 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| ABBVIE INC. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: ABILIFY MAINTENA, ABILIFY ASIMTUFII, COBENFY, VRAYLAR, REXULTI, TRINTELLIX.
Industry payments across CO — which companies pay providers there.
